GDIR agonist: Phase I start

In 2008, Johnson & Johnson's Ortho-McNeil Pharmaceutical Inc. unit will begin Phase I

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE